Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Sup Lee

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
World Journal of Gastroenterology|March 15, 2012
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancerLee Chun Park, Ho Sup Lee, Seong Hoon Shin, et al.
International Journal of Cancer|April 12, 2019
The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patientsLee Chun Park, Yeon-Joo Song, Da Jung Kim, et al.
Annals of Hematology|July 31, 2013
Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemiaHo Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
Annals of Hematology|January 13, 2012
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairmentMoo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, et al.
Yeungnam University Journal of Medicine|October 18, 2019
Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimenHee-Jeong Cho, Sang-Kyung Seo, Dong Won Baek, et al.
International Journal of Hematology|October 7, 2018
Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasoneJunghoon Shin, Je-Jung Lee, Kihyun Kim, et al.
BMC Cancer|August 25, 2020
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myelomaGa-Young Song, Sung-Hoon Jung, Kihyun Kim, et al.
Journal of Molecular Biology|October 7, 2004
Characterization of an actin-binding site within the talin FERM domainHo-Sup Lee, Robert M Bellin, Diane L Walker, et al.
Leukemia Research|August 22, 2017
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series studyJe-Hwan Lee, Yoo-Jin Kim, Sang Kyun Sohn, et al.
Blood Research|November 30, 2023
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO studySeok Jin Kim, Young Rok Do, Ho-Sup Lee, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
World Journal of Gastroenterology|March 15, 2012
Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancerLee Chun Park, Ho Sup Lee, Seong Hoon Shin, et al.
International Journal of Cancer|April 12, 2019
The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patientsLee Chun Park, Yeon-Joo Song, Da Jung Kim, et al.
Annals of Hematology|July 31, 2013
Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemiaHo Sup Lee, Lee Chun Park, Eun Mi Lee, et al.
Annals of Hematology|January 13, 2012
Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairmentMoo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, et al.
Yeungnam University Journal of Medicine|October 18, 2019
Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimenHee-Jeong Cho, Sang-Kyung Seo, Dong Won Baek, et al.
International Journal of Hematology|October 7, 2018
Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasoneJunghoon Shin, Je-Jung Lee, Kihyun Kim, et al.
BMC Cancer|August 25, 2020
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myelomaGa-Young Song, Sung-Hoon Jung, Kihyun Kim, et al.
Journal of Molecular Biology|October 7, 2004
Characterization of an actin-binding site within the talin FERM domainHo-Sup Lee, Robert M Bellin, Diane L Walker, et al.
Leukemia Research|August 22, 2017
Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series studyJe-Hwan Lee, Yoo-Jin Kim, Sang Kyun Sohn, et al.
Blood Research|November 30, 2023
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO studySeok Jin Kim, Young Rok Do, Ho-Sup Lee, et al.
Pageof 14